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a  b  s  t  r  a  c  t
Objective: To assess whether serum vitamin D concentration is associated with gait sta-
tus and mortality among patients with fractures of the proximal femur, six months after
suffering the fracture.
Methods: Consecutive patients aged ≥65 years with fractures of the proximal femur, who
were admitted to the orthopedics and traumatology ward of our service between January and
December 2011, were prospectively evaluated. Clinical, radiological, epidemiological and
laboratory analyses were performed, including vitamin D. The patients underwent surgery
and were followed up as outpatients, with return visits 15, 30, 60 and 180 days after discharge,
at  which the outcomes of gait and mortality were evaluated.
Results: Eighty-eight patients were evaluated. Two of them were excluded because they pre-
sented oncological fractures. Thus, 86 patients of mean age 80.2 ± 7.3 years were studied.
In  relation to serum vitamin D, the mean was 27.8 ± 14.5 ng/mL, and 33.7% of the patients
presented deﬁciency of this vitamin. In relation to gait, univariate and multivariate logis-
tic regression showed that vitamin D deﬁciency was not associated with gait recovery, even
after  adjustment for gender, age and type of fracture (OR: 1.463; 95% CI: 0.524–4.088; p = 0.469).
Regarding mortality, Cox regression analysis showed that vitamin D deﬁciency was not
related to its occurrence within six months, even in multivariate analysis (HR: 0.627; 95% CI:
0.180–2.191; p = 0.465).
Conclusion: Serum vitamin D concentration was not related to gait status and/or mortality
among patients with fractures of the proximal femur, six months after suffering the fracture.©  2015 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora
Ltda. All rights reserved.
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Associac¸ão  da  deﬁciência  de  vitamina  D  com  mortalidade  e  marcha






r  e  s  u  m  o
Objetivo: Avaliar se a concentrac¸ão sérica de vitamina D está associada ao status de marcha
e  à mortalidade em pacientes com fratura de fêmur proximal seis meses após a fratura.
Métodos: Avaliados prospectivamente pacientes consecutivos com fratura de fêmur proxi-
mal,  com idade ≥ 65 anos, internados na enfermaria de ortopedia e traumatologia do servic¸o,
entre janeiro a dezembro de 2011. Foram feitas análises clínica, radiológica, epidemiológica
e  laboratorial, incluindo vitamina D. Foram submetidos à cirurgia e acompanhados ambu-
latorialmente em retornos 15, 30, 60 e 180 dias após a alta, quando foram avaliados os
desfechos de marcha e mortalidade.
Resultados: Avaliados 88 pacientes. Dois foram excluídos por causa de fratura patológica.
Oitenta e seis pacientes com idade média de 80,2 ± 7,3 anos foram estudados. Em relac¸ão
à  vitamina D sérica a média foi de 27,8 ± 14,5 ng/mL e 33,7% dos pacientes apresentavam
deﬁciência dessa vitamina. Em relac¸ão à marcha, a análise de regressão logística uni e mul-
tivariada mostrou que a deﬁciência de vitamina D não esteve associada a sua recuperac¸ão,
mesmo após ajuste por gênero, idade e tipo de fratura (OR 1,463; 95% IC 0,524-4,088; p = 0,469).
Considerando a mortalidade, a análise de regressão de Cox mostrou que a deﬁciência de vita-
mina D também não esteve relacionada à sua ocorrência em seis meses, mesmo na análise
multivariada (HR 0,627; 95% IC 0,180-2,191; p = 0,465).
Conclusão: A concentrac¸ão de vitamina D sérica não esteve relacionada ao status de marcha
e/ou  à mortalidade em paciente com fratura de fêmur proximal seis meses depois dela.
©  2015 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por Elsevier
Editora Ltda. Todos os direitos reservados.Introduction
The incidence of fractures of the proximal femur has increased
over recent decades and there is an expectation that it will
continue to increase because of the aging of the population.1,2
It is expected that by 2020, 16.3% of the American popula-
tion and 25% of the Canadian population will be over the
age of 65 years.2 This increase in the numbers of elderly
individuals will probably give rise to higher incidence and
prevalence of diseases of the musculoskeletal system, such
as fractures secondary to osteoporosis and osteoarthrosis.
According to Thorngren, the number of cases of hip fractures
among patients over the age of 80 years has doubled over the
last 20 years.3 According to Hu et al.,4 1.5 million cases of hip
fractures occur around the world and this number may reach
2.6 million in 2025 and 4.5 million in 2050.
Fractures secondary to bone fragility, especially those
occurring in the proximal femur, have been correlated with
signiﬁcant reductions in independence and increased mor-
bidity and mortality.5 According to Holt et al.,6 only 22% of
the patients who, before the fracture occurred, were able to
walk without support and unaccompanied recover this level
of independence within the ﬁrst 120 days after the event. This
loss of independence is even more  serious among patients
over the age of 95 years: in this group, only 2% recover their
preoperative ability to walk within the same period. Further-
more,  the mortality rates relating to fractures of the proximal
femur are very high and may range from 14% to 47% over the
ﬁrst year after their occurrence. All of these points empha-
size the importance of and interest in recovering the ability towalk and improving the prognosis, for patients with this type
of fracture.6
Among the micronutrients relating to the risk of falls and
fractures among elderly people, vitamin D can be highlighted.
This is a liposoluble micronutrient with a function classically
related to increased intestinal absorption of calcium, which
participates in active transportation of this ion in entero-
cytes. It also participates in mobilizing calcium in bones, in
the presence of PTH, and in increasing the renal reabsorp-
tion of calcium in the distal tubule.7 However, new functions
have now been attributed to vitamin D. Studies have shown
that it has an important role in modulating inﬂammatory
and immunological processes, and that it may have a rela-
tionship with wound healing and with alterations to muscle
mass and strength.8,9 Higher vitamin D concentrations have
been correlated with lower fall rates among elderly patients.
Consequently, this diminishes the risk of new fractures.10
The objectives of this study were to evaluate the demo-
graphic, clinical and biochemical characteristics of patients
with and without vitamin D insufﬁciency and to ascertain
whether the serum concentration of this nutrient is associ-
ated with walking status and with mortality among patients
with fractures of the proximal femur, six months after the
occurrence.
Sample  and  methodsThe present study was approved by our institution’s ethics
committee and all the patients or the persons legally respon-
sible for them signed a free and informed consent statement.
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onsecutive patients of ages ≥65 years with fractures of the
roximal femur who  were hospitalized in the orthopedics
nd traumatology ward of our service between January and
ecember 2011 were prospectively evaluated. The exclusion
riterion was the presence of pathological fractures (sec-
ndary to neoplasia). All the patients underwent a surgical
rocedure to correct the facture.
On admission, the patients’ demographic data were reg-
stered. During the ﬁrst 72 hours of their hospital stay, blood
amples were collected for laboratory tests, including mea-
urement of serum 25(OH) vitamin D3. Data relating to
he type of fracture of the proximal femur (femoral neck,
ntertrochanteric or subtrochanteric fracture), length of the
aiting time between hospital admission and surgery and
uration of the operation were also recorded. The patients
ere followed up for up to six months after the occurrence
f the fracture and were assessed in relation to postoperative
alking status and mortality. These assessments were made
n the ﬁrst day after the surgical procedure, at the time of hos-
ital discharge and at return visits 15, 30, 60 and 180 days after
ischarge. For patients who  died before reaching 180 days, the
alking status assessment of the last return visit was taken
nto consideration.
Vitamin D deﬁciency was characterized as a serum concen-
ration lower than 20 ng/mL.11 In relation to walking status,
he patients were classiﬁed as walkers (who were walking with
r without support = 1) and non-walkers (who were unable to
alk = 0).
aboratory  assessment
he blood samples collected over the ﬁrst 72 hours after the
atient’s admission were used for laboratory tests, including
he vitamin D levels.
To produce a hemogram,  an automated method in a Coul-
er STKS auto-analyzer was used, followed by conﬁrmation
f the morphological ﬁndings, platelet counts, leukome-
ry and leukocyte differentials, by means of a conventional
ematoscopy method. To assay the sodium, potassium, mag-
esium, total calcium, glycemia, urea, creatinine, C-reactive
rotein and albumin levels, a dry chemical method was used
Ortho-Clinical Diagnostics Vitros 950®, Johnson & Johnson).
rothrombin time (PT) and activated partial thromboplastin
ime (APTT) were obtained using manual methods.
etermination  of  25(OH)  vitamin  D3  in  serum
he concentrations of 25(OH) vitamin D3 in serum were
nalyzed by means of high-performance liquid chromatog-
aphy (HPLC). Initially, 150 L of serum was pipette into a
lass ﬂask; 200 L of precipitating reagent were added and
he mixture was vortex-stirred for 30 seconds. Following this,
00 L of extraction reagent were added and the mixture was
gain vortex-stirred for another 30 seconds. It was then cen-
rifuged for 10 min  at 13,000 rpm. The supernatant was then
ransferred to another glass ﬂask, evaporated with nitrogen,
esuspended with 300 L of ethanol and stirred for another
inute. Following this, 20 L were injected into the HPLC
pparatus. After running this for 20 min, the column was left
o stabilize so that a new reading could be made.;5 0(2):153–158 155
The equipment used was the isocratic HPLC with a
manual Rheodyne injector and a 20 L loop. The analy-
sis was performed in a 4 m silica column of dimensions
125 mm × 4 mm (KC 3420RP; Immundiagnostik). The ultravio-
let wavelength detector was set at 264 nm and the ﬂow was set
at 0.75 mL/min. The mobile phase was supplied by the manu-
facturer (Immundiagnostik). The internal standard used was
from Sigma–Aldrich (C9774) and the control was from Chrom-
systems (25 [OH] vitamin D3 serum control, bi-level I + II). The
test sensitivity was 2.5 g/L and the coefﬁcient of variation was
<7%.12,13
Statistical  analysis
The data were presented as means and standard deviations
or as medians and 25th and 75th percentiles. The categor-
ical variables were analyzed by means of the 2 or Fisher
test. The continuous variables were analyzed using Student’s
t test when they presented parametric distribution or using
the Mann–Whitney test when they presented nonparametric
distribution. To assess whether the 25(OH) vitamin D3 lev-
els were associated with recovery of the ability to walk 180
days after the fracturing, we  used uni and multivariate logis-
tic regression. In order to evaluate mortality, we  used the Cox
proportional hazards model. In the multivariate analyses, the
variables were adjusted according to gender, age and type of
fracture. The signiﬁcance level was taken to be 5%.
Results
Eighty-eight consecutive patients with fractures of the prox-
imal femur were evaluated. Of these, two  were excluded
because their fractures were pathological. Thus, 86 patients
of mean age 80.2 ± 7.3 years were evaluated. Among these
patients, 77% were women, 70% presented recovery of the
ability to walk and 12.8% had died by the sixth month after
the fracture event. In relation to serum vitamin D, the mean
concentration was 27.8 ± 14.5 ng/mL and 33.7% of the patients
presented deﬁciencies of this vitamin.
The demographic and clinical data on the patients accord-
ing to their serum vitamin D concentrations are presented in
Table 1. The majority of the patients hospitalized presented
transtrochanteric fractures (55%) and fractures of the femoral
neck (38%). The vitamin D concentration did not have any
inﬂuence on the type of fracture. Moreover, vitamin D deﬁ-
ciencies did not present any associations with the clinical
and demographic data on the patients evaluated (Table 1).
The biochemical data are presented in Table 2. There were no
differences regarding the laboratory test results between the
groups with and without vitamin D deﬁciencies.
In relation to walking, the uni and multivariate logistic
regression analyses showed that the vitamin D deﬁciencies did
not have any association with recovery of the ability to walk
(OR 1.212; 95% CI 0.451–3.252; p = 0.703), even after adjustment
according to gender, age and type of fracture (OR 1.463; 95% CI
0.524–4.088; p = 0.469) (Table 3).
With regard to mortality, the Cox regression analysis
showed that the vitamin D deﬁciencies also did not have any
correlation with occurrences of mortality within the ﬁrst six
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Table 1 – Clinical and demographic variables of the patients with fractures of the proximal femur, according to their
serum vitamin D concentration.
Variables Serum vitamin D (25OH vit D3) p value
≥20 ng/mL (n = 57) <20 ng/mL (n = 29)
Age (years) 79.8 ± 6.7 81.0 ± 8.3 0.475
Female sex, n (%) 47 (82.5) 19 (65.5) 0.137
Preoperative hospital stay (days) 6 (4–8) 4 (3–7.5) 0.091
Duration of operation (min) 70 (50–90) 65 (50–90) 0.667
Type of fracture, n (%) 0.590
Femoral neck 24 (42) 9 (31)
Transtrochanteric 29 (51) 18 (62)
Subtrochanteric 4 (7) 2  (7)
SAH, n (%) 37 (64.9) 14 (48.3) 0.210
DM type II, n (%) 14 (24.6) 6 (20.7) 0.895
Recovery of ability to walk, n (%) 39 (68.4) 21 (72.4) 0.894
Death, n (%) 6 (10.5) 5 (17.2) 0.497
Table 2 – Laboratory variables among the patients with fractures of the proximal femur, according to their serum vitamin
D concentrations.
Variables Serum vitamin D (25OH vit D3) p  value
≥20 ng/mL (n = 57) <20 ng/mL (n = 29)
Hematocrit (%) 34.5 ± 6.2 34.0 ± 7.5 0.755
Hemoglobin (g/L) 12.1 (10.5–12.9) 11.9 (9.6–13.4) 0.924
Platelets (×103/L) 206 (157–258) 196 (158–251) 0.756
Leukocytes (×103/L) 8.200 (6.550–10.450) 7.700 (5.750–9.750) 0.267
PT 1.05 (1.0–1.13) 1.07(1.04–1.14) 0.217
APTT 1.06 (0.93–1.18) 1.05 (0.97–1.22) 0.689
CRP (mg/dL) 5.2 (3.6–8.8) 4.6 (3.0–17.8) 0.491
Sodium (mmoL/L) 138 (136–141) 139 (137–141) 0.745
Potassium (mmoL/L) 4.1 (3.9–4.4) 4.2 (3.7–4.7) 0.701
Magnesium (mg/dL) 2.0 (1.8–2.1) 1.9 (1.7–2.1) 0.498
Total calcium (mg/dL) 8.78 ± 0.58 8.72 ± 0.61 0.625
Urea (mg/dL) 52 (36–72) 58 (39–75) 0.698
Creatinine (mg/dL) 0.80 (0.70–1.11) 0.80 (0.65–1.05) 0.528
Glycemia (mg/dL) 119 (95–150) 
Albumin (g/dL) 3.22 ± 0.49
months (HR 0.565; 95% CI 0.172–1.853; p = 0.346), even in the
multivariate analysis (HR 0.627; 95% CI 0.180–2.191; p = 0.465)
(Table 4).
Discussion
The increase in the size of the elderly population has been
accompanied by the presence of events such as fractures of
the proximal femur. After fractures have occurred, loss of
independence, particularly with regard to returning to the pre-
fracture walking status, is a frequent complication that often
Table 3 – Logistic regression for predicting recovery of the abilit
femur.
Odds ratio 
Vitamin D < 20 ng/mL 1.212 
Vitamin D < 20 ng/mLa 1.439 
Vitamin D < 20 ng/mLb 1.463 
a Adjusted for gender and age.
b Adjusted for gender, age and type of fracture.128 (97–146) 0.827
3.16 ± 0.50 0.585
brings devastating consequences for patients and their care-
givers in relation to quality of life.6 Mortality may also occur.
Thus, it becomes important to identify factors that might be
associated with recovery of the ability to walk or with mor-
tality. It has been suggested that the micronutrient vitamin
D has potential effects on muscle strength and in relation to
mortality. Thus, the present study compared demographic,
clinical and biochemical parameters in patients with and
without vitamin D deﬁciencies. In addition, the serum vita-
min  D concentrations were analyzed as potential predictors
of recovery of the ability to walk or as predictors of mortal-
ity.
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Table 4 – Cox regressions for predicting mortality among patients with fractures of the proximal femur.
Hazard ratio 95% CI p
Vitamin D < 20 ng/mL 0.565 0.172–1.853 0.346
Vitamin D < 20 ng/mLa 0.639 0.189–2.163 0.471















































ra Adjusted for gender and age.
b Adjusted for gender, age and type of fracture.
With regard to vitamin D deﬁciency, patients presenting
oncentrations lower than 20 ng/mL were compared with
hose whose concentrations were higher than this. The two
roups presented the same demographic, clinical and bio-
hemical characteristics. In fact, it is not known whether
hese concentrations are sufﬁcient for non-classical actions
f vitamin D. There is no consensus in the literature regarding
hat the normal serum vitamin D concentration would be,
f in relation to the levels that would characterize deﬁciency
nd insufﬁciency of this micronutrient.14 These values have
lways been based on the relationship between vitamin D
oncentrations and disorders involving calcium homeostasis
nd fracture occurrences. With regard to the new functions
escribed, the vitamin D concentration that is sufﬁcient for
ction at these different sites has not yet been established.
In Canada, the International Osteoporosis Foundation has
ecommended that the serum vitamin D concentration should
e greater than 30 ng/mL.15,16 On the other hand, the Institute
f Medicine of the American National Academies has char-
cterized vitamin D deﬁciency as serum concentration lower
han 12 ng/mL and vitamin D insufﬁciency as concentrations
etween 12 and 20 ng/mL.17
In relation to recovery of the ability to walk, Cooper stated
hat fractures are related to a permanent incapacity rate of
0% with regard to activities of daily living and an incapac-
ty rate of 40% with regard to walking independently.18 Larson
t al.19 observed the functional recovery of patients with frac-
ures of the proximal femur, among 607 patients. Among these
articipants, 446 had been able to walk independently with-
ut support before the surgery and 80% were found to have
ecovered their preoperative walking status one year after the
urgery. Ekstrom et al.20 found that only 55% of the patients
ith fractures of the proximal femur recovered their preoper-
tive walking status, while 66% recovered their preoperative
erformance level with regard to activities of daily living. We
ut forward the hypothesis that the serum vitamin D con-
entration might inﬂuence this postoperative walking status.
his was based on the functions most recently attributed to
itamin D. Classically, vitamin D has been correlated with
aintenance of calcium homeostasis, but it has recently also
een correlated with muscle contraction through intracellular
alcium uptake and differentiation of myoblasts. This would
iminish the incidence of falls and consequently the number
f fractures.10 In patients with fractures, this would increase
he chance of achieving better postoperative walking status.
n our study, the serum vitamin D concentration did not show
ny correlation with the postoperative walking status, even in
he corrected analysis.
With regard to mortality, the advent for surgical ﬁxation of
ractures of the proximal femur reduced this. However, sincethen, it has remained stable at 25–30%.21 In our study, the
rate was 12.8% within six months. The relationship between
serum vitamin D concentration and mortality has been little
studied. Some studies have shown that low serum concen-
tration is associated with higher mortality in the general
population and among elderly people.22–27 In a study with
more  than 180,000 participants, Saliba et al.28 showed that
the risk of death due to all causes was signiﬁcantly higher
among patients with low serum vitamin D concentration
(lower than 50 nmoL/L). In patients in whom the concentra-
tions are lower than 30 nmoL/L (deﬁciency), this risk becomes
doubled. Thomas et al. showed that adequate vitamin D levels
reduced mortality due to all causes and due to cardiovascu-
lar causes by 75% and 69%, respectively, among patients with
metabolic syndrome.29
In the literature, we  found few studies that evaluated the
serum vitamin D concentration and mortality among patients
with fractures of the proximal femur. In a study that included
562 patients over the age of 70 years with these fractures,
Madsen et al.30 concluded that PTH and serum calcium were
signiﬁcantly associated with mortality, but not vitamin D
concentration. Likewise, in our study, serum vitamin D con-
centrations did not show any association with mortality six
months after the occurrence of fractures of the proximal
femur.
Conclusion
In conclusion, in our study, serum vitamin D concentrations
did not have any correlation with walking status or with mor-
tality among patients with fractures of the proximal femur, six
months after the event. The ﬁndings from this study empha-
size that there is a need for further studies that might identify
factors predictive of complications subsequent to fractures of
the proximal femur.
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